Bone Marrow TransplantationTransplantation, AutologousBone Marrow PurgingBone MarrowTransplantation, HomologousBone Marrow CellsWhole-Body IrradiationCombined Modality TherapyCyclophosphamideCarmustineLymphoma, Non-HodgkinMelphalanGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsRemission InductionHematopoietic Stem Cell TransplantationEtoposideBusulfanTransplantation ConditioningHodgkin DiseaseCytarabineLeukemia, Myeloid, AcuteLeukemiaRecurrenceHematopoietic Stem CellsColony-Forming Units AssayBone and BonesLeukemia, MyeloidActuarial AnalysisTreatment OutcomeGraft SurvivalBone Marrow DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisVincristinePodophyllotoxinAnemia, AplasticSurvival AnalysisDrug EvaluationLiver TransplantationSalvage TherapyTransplantation ChimeraLymphomaThiotepaTime FactorsTissue DonorsDisease-Free SurvivalAcute DiseaseTransplantation, IsogeneicSurvival RateFollow-Up StudiesLeukocyte CountHistocompatibility TestingStem Cell TransplantationHistocompatibilityGranulocyte Colony-Stimulating FactorLymphatic IrradiationMitoxantronePrednisoneMyelodysplastic SyndromesImmunosuppressionGranulocyte-Macrophage Colony-Stimulating FactorMultiple MyelomaRetrospective StudiesPrognosisKidney TransplantationPlatelet CountLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeuroblastomaHepatic Veno-Occlusive DiseaseDoxorubicinMesnaBlood Cell CountGonadal DisordersOvarian Function TestsGranulocytesAntibodies, MonoclonalT-LymphocytesCyclosporineProspective StudiesImmunosuppressive AgentsHematologic DiseasesRicinPrednimustineNeutropeniaMice, Inbred C57BLRadiation ChimeraLymphoma, FollicularBone Marrow ExaminationVindesineHematologic NeoplasmsAgranulocytosisLomustineCell SeparationGraft RejectionLife TablesBone RemodelingNeoplasm, ResidualBone Marrow NeoplasmsTransplantation Immunology